Skip to content

Prevention of Recurrent Preterm Delivery by a Natural Progesterone Agent

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00329316
Enrollment
Unknown
Registered
2006-05-24
Start date
Unknown
Completion date
Unknown
Last updated
2008-06-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy, Premature Birth

Keywords

Pre-term labor, progesterone

Brief summary

To examine the preterm delivery rate of a preterm delivery high risk group of pregnant women, using once daily natural progesterone agent.

Interventions

DRUGCrinone Gel 8%

Sponsors

The Baruch Padeh Medical Center, Poriya
Lead SponsorOTHER_GOV

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
No

Inclusion criteria

Pregnancy 24 weeks' gestation Preterm labor in previous pregnancies \-

Exclusion criteria

* No medications for PTL or any kind of progesterone. * Cervical suture * Multiple pregnancy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026